& McKesson Shareholders:
Atorvastatin Supply Issues Could Trigger Price Rise
Rumors of price increases on atorvastatin have been circulating for months. There are five current manufacturers of this product, but Apotex has experienced significant inventory issues and we have noticed a run on inventory with secondary sources.
Although this number of manufacturers should reduce the risk of significant increases, we are concerned that the disruption in supply may trigger an increase with manufacturers able to ship. Due to the current low price, we recommend carrying extra inventory of this product at least until the supply chain stabilizes.
On average, it takes more than 37 days for MACs to be adjusted when there is a generic increase, and often can take longer in many cases. In order to protect your margin, we recommend that you purchase enough inventory to carry you through this period of lagging reimbursement.